Maximilian von EYNATTEN
14Patents
5h-index
17Co-inventors
55Inventor score
Filing activity: Oct 21, 2015 → Nov 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9949997B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 16 | Active |
| US9949998B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 15 | Active |
| US10258637B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 14 | Active |
| US10155000B2 | Medical use of pharmaceutical combination or composition | Human Necessities | 11 | Active |
| US11090323B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 6 | Active |
| US11666590B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 3 | Active |
| US11833166B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 2 | Active |
| US9526730B2 | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome | Chemistry; Metallurgy | 2 | Active |
| US11918596B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 0 | Active |
| US12364700B2 | Medical use of pharmaceutical combination or composition | Human Necessities | 0 | Active |
| US12263153B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 0 | Active |
| US10195203B2 | Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome | Chemistry; Metallurgy | 0 | Active |
| US12427162B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 0 | Active |
| US11813275B2 | Pharmaceutical composition, methods for treating and uses thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.